Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 2R1X | 2R1X | Crystal structure of S25-2 Fab in complex with Kdo analogues | |
| 2R1Y | 2R1Y | Crystal structure of S25-2 Fab in complex with Kdo analogues | |
| 2R23 | 2R23 | Crystal structure of S25-2 Fab in complex with Kdo analogues | |
| 2R2B | 2R2B | Crystal structure of S25-2 Fab in complex with Kdo analogues | |
| 2R2E | 2R2E | Crystal structure of S25-2 Fab in complex with Kdo analogues | |
| 4HGW | 4HGW | Crystal structure of S25-2 in complex with a 5,6-dehydro-Kdo disaccharide | |
| 4M7J | 4M7J | Crystal structure of S25-26 in complex with Kdo(2.8)Kdo(2.4)Kdo trisaccharide | |
| 3OKD | 3OKD | Crystal structure of S25-39 in complex with Kdo | |
| 3OKK | 3OKK | Crystal structure of S25-39 in complex with Kdo(2.4)Kdo | |
| 3OKN | 3OKN | Crystal structure of S25-39 in complex with Kdo(2.4)Kdo(2.4)Kdo | |
| 3OKL | 3OKL | Crystal structure of S25-39 in complex with Kdo(2.8)Kdo | |
| 3OKO | 3OKO | Crystal structure of S25-39 in complex with Kdo(2.8)Kdo(2.4)Kdo | |
| 3OKE | 3OKE | Crystal structure of S25-39 in complex with Ko | |
| 7WD2 | P0DTC2 | Crystal structure of S43 bound to SARS-CoV-2 RBD | |
| 7WD2 | 7WD2 | Crystal structure of S43 bound to SARS-CoV-2 RBD | |
| 3I02 | 3I02 | Crystal structure of S54-10 antibody in complex with antigen Kdo(2.4)Kdo(2.4)Kdo | |
| 3PHQ | 3PHQ | Crystal structure of S64-4 in complex with KDO | |
| 3PHO | 3PHO | Crystal structure of S64-4 in complex with PSBP | |
| 3HZM | 3HZM | Crystal structure of S73-2 antibody in complex with antigen Kdo | |
| 3HZK | 3HZK | Crystal structure of S73-2 antibody in complex with antigen Kdo(2.4)Kdo | |
| 3HZY | 3HZY | Crystal structure of S73-2 antibody in complex with antigen Kdo(2.4)Kdo(2.4)Kdo | |
| 3HZV | 3HZV | Crystal structure of S73-2 antibody in complex with antigen Kdo(2.8)Kdo(2.4)Kdo | |
| 6E3H | Q5EP31 | Crystal structure of S9-3-37 bound to H5 influenza hemagglutinin | |
| 6E3H | 6E3H | Crystal structure of S9-3-37 bound to H5 influenza hemagglutinin | |
| 3DUR | 3DUR | Crystal structure of SAG173-04 | |
| 3DUS | 3DUS | Crystal structure of SAG506-01, orthorhombic, twinned, crystal 1 | |
| 3DUU | 3DUU | Crystal structure of SAG506-01, orthorhombic, twinned, crystal 2 | |
| 3DV4 | 3DV4 | Crystal structure of SAG506-01, tetragonal, crystal 1 | |
| 3DV6 | 3DV6 | Crystal structure of SAG506-01, tetragonal, crystal 2 | |
| 5XWS | Q96NI6 | Crystal structure of SALM5 LRR-Ig | |
| 5GVY | A2WPN7 | Crystal structure of SALT protein from Oryza sativa | |
| 8KD0 | Q4FMK2 | Crystal structure of SAR11_0769 from 'Candidatus Pelagibacter ubique' HTCC1062 bound to a co-purified ligand, beta-galactopyranose | |
| 7S83 | 7S83 | Crystal structure of SARS CoV-2 Spike Receptor Binding Domain in complex with shark neutralizing VNARs ShAb01 and ShAb02 | |
| 7S83 | P0DTC2 | Crystal structure of SARS CoV-2 Spike Receptor Binding Domain in complex with shark neutralizing VNARs ShAb01 and ShAb02 | |
| 7FC6 | F6V9L3 | Crystal structure of SARS-CoV RBD and horse ACE2 | |
| 7FC6 | P59594 | Crystal structure of SARS-CoV RBD and horse ACE2 | |
| 7Y3N | P59594 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 | |
| 7Y3N | 7Y3N | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 | |
| 7JN5 | Q19QX0 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
| 7JN5 | 7JN5 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
| 7LM9 | D2E265 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7LM9 | 7LM9 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 8WCG | P59594 | Crystal structure of SARS-CoV-1 RBD in complex with nanobody aSR29 and aSR347 | |
| 8WCG | 8WCG | Crystal structure of SARS-CoV-1 RBD in complex with nanobody aSR29 and aSR347 | |
| 7S5Q | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
| 7S5Q | 7S5Q | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
| 7S5P | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
| 7S5P | 7S5P | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
| 8GB8 | P0DTC2 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB8 | 8GB8 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 |
